In short. What a vial sold as an exosome actually contains, what a laboratory would have to measure to say, and the three facts a label rarely provides.
Key points
- Calling a preparation an exosome product does not state that it contains exosomes, how many, or by what method anyone checked.
- Those are three separate claims, and a product making the first without the other two has told you nothing about the liquid in the vial.
The word exosome names a specific biological structure: a small vesicle, bounded by a lipid membrane, that a cell releases and that carries proteins and nucleic acids from the cell that made it. Identifying one in a laboratory is a defined procedure. The material has to be separated from everything else in the liquid and then shown to be what it is claimed to be, using specified markers and a method that can see particles of that size.
What is usually in the vial
Products sold for injection under this name are rarely accompanied by that evidence. When independent laboratories have looked, what they found has often been a mixture: proteins, salts, sugars, remnants of culture medium, and particles of many sizes, with the content the name refers to either low or not measurable at all. A preparation can be described as exosome-rich while nothing on the label states how much of it is exosome, how that was measured, or what the measurement found. Without those three facts, the word describes an intention rather than contents.
A second difficulty sits behind the first. Many counting methods register all particles, not exosomes specifically. A number produced that way can be accurate and still say nothing about how much of the material has the structure the name refers to, and it is the kind of number that reads like a dose when it is nothing of the sort.
A name is not a measurement
Calling a preparation an exosome product does not state that it contains exosomes, how many, or by what method anyone checked. Those are three separate claims, and a product making the first without the other two has told you nothing about the liquid in the vial.
What else travels with it
Material derived from cultured cells or from tissue carries whatever else was in the source. That includes residual culture medium, and it can include micro-organisms if the source was not screened and the preparation was not treated to reduce them. Sterility does not follow from material being biological. It has to be demonstrated batch by batch, and the demonstration is a laboratory result rather than a claim.
What can be checked, and what cannot
A document that can be checked names the source, the markers, the method, the result and the sterility test, and it traces to a batch. One that cannot be checked names the product and asserts a quality. The difference between them is the whole of it: one can be assessed afterwards, and the other leaves no usable trace.
Three things a label rarely states
- What the material was derived from, and how that source was screened.
- How the particle content was measured, and what the measurement actually found.
- Which batch the vial came from, so a problem can be traced back to it later.
None of this argues that the biology is imaginary. It argues that the vial and the biology are two different things, and only one of them has been studied.
Frequently asked questions
If a vial contains no measurable exosomes, what is being injected?
Material from the source the product was made from, together with whatever else travelled with it: proteins, salts, sugars, fragments of culture medium, and particles across a range of sizes. That mixture may be biologically active in some way. What it is not is a preparation whose content has been stated, measured and shown to be consistent from batch to batch.
What would a meaningful laboratory document for one of these products state?
The source of the cells or tissue, the markers used to identify the particles, the method used to measure them, the result of that measurement, and the result of a sterility test. It would be signed, dated and traceable to a batch. A document that names the product and asserts a quality without any of those details lets a reader verify nothing.
Does a particle count tell me how much exosome is in a product?
Usually not. Many counting methods register every particle in a size range rather than the specific structure the name refers to, so a large number can be accurate and still say nothing about exosome content. A count is also easy to present as though it were a dose, which is a separate claim again.
Risks & Limitations
- No product marketed as an exosome injectable has been through the approval process that would establish what it contains or what it does.
- Birth tissue derived material carries an infection risk when it is injected, and serious infections have been reported after such injections.
- The evidence behind most claims comes from laboratory work, animal models or uncontrolled case series, none of which establishes an effect in people.
- Regulatory status differs by country, and in most markets there is no approval for these products in any injectable use.
- Nothing on this site is a recommendation for or against any treatment, and it does not assess individual cases.
When to Seek Care
- Spreading redness, heat, swelling or discharge at an injection site: have it assessed promptly.
- Fever, or feeling unwell with a painful injected area: seek medical care without waiting.
- Severe or worsening pain, blistering, or skin breakdown where something was injected.
- Any new and persistent symptom after a treatment: have it assessed by a clinician who can examine you.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.